Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom Suk Lee

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Therapy Oncolytics|October 26, 2020
Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and PrognosisRaj Kumar Mongre, Chandra Bhushan Mishra, Samil Jung, et al.
Biochemical and Biophysical Research Communications|May 24, 2017
Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticlesMyung Goo Kim, Sung Duk Jo, Ji Young Yhee, et al.
Molecules and Cells|February 14, 2020
Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum StarvationZolzaya Sandag, Samil Jung, Nguyen Thi Ngoc Quynh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 13, 2016
Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targetingKyungim Kim, Keun Sang Oh, Dal Yong Park, et al.
Biomedicines|May 28, 2022
SERTAD1 Sensitizes Breast Cancer Cells to Doxorubicin and Promotes Lysosomal Protein BiosynthesisHai Anh Nguyen, Son Hai Vu, Samil Jung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drugBeom Suk Lee, Kyeongsoon Park, Sangjin Park, et al.
Biomaterials|September 27, 2012
Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic chargeSeung Woo Chung, Myungjin Lee, Sang Mun Bae, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
PEG-PLA-Coated and Uncoated Radio-Luminescent CaWO<sub>4</sub> Micro- and Nanoparticles for Concomitant Radiation and UV-A/Radio-Enhancement Cancer TreatmentsSung Duk Jo, Jaewon Lee, Min Kyung Joo, et al.
Journal of the National Cancer Institute|December 16, 2014
Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapyBeom Suk Lee, Yong Woo Cho, Gui Chul Kim, et al.
International Journal of Cancer|June 22, 2017
Radiotherapy-assisted tumor selective metronomic oral chemotherapySeung Woo Chung, Seho Kweon, Beom Suk Lee, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Therapy Oncolytics|October 26, 2020
Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and PrognosisRaj Kumar Mongre, Chandra Bhushan Mishra, Samil Jung, et al.
Biochemical and Biophysical Research Communications|May 24, 2017
Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticlesMyung Goo Kim, Sung Duk Jo, Ji Young Yhee, et al.
Molecules and Cells|February 14, 2020
Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum StarvationZolzaya Sandag, Samil Jung, Nguyen Thi Ngoc Quynh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 13, 2016
Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targetingKyungim Kim, Keun Sang Oh, Dal Yong Park, et al.
Biomedicines|May 28, 2022
SERTAD1 Sensitizes Breast Cancer Cells to Doxorubicin and Promotes Lysosomal Protein BiosynthesisHai Anh Nguyen, Son Hai Vu, Samil Jung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drugBeom Suk Lee, Kyeongsoon Park, Sangjin Park, et al.
Biomaterials|September 27, 2012
Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic chargeSeung Woo Chung, Myungjin Lee, Sang Mun Bae, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
PEG-PLA-Coated and Uncoated Radio-Luminescent CaWO<sub>4</sub> Micro- and Nanoparticles for Concomitant Radiation and UV-A/Radio-Enhancement Cancer TreatmentsSung Duk Jo, Jaewon Lee, Min Kyung Joo, et al.
Journal of the National Cancer Institute|December 16, 2014
Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapyBeom Suk Lee, Yong Woo Cho, Gui Chul Kim, et al.
International Journal of Cancer|June 22, 2017
Radiotherapy-assisted tumor selective metronomic oral chemotherapySeung Woo Chung, Seho Kweon, Beom Suk Lee, et al.
Pageof 3